Standout Papers

Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced es... 2022 2026 2023 2024145
  1. Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma (2022)
    Jun Liu, Yang Yang et al. Journal for ImmunoTherapy of Cancer
  2. Tryptophan Metabolism Acts as a New Anti‐Ferroptotic Pathway to Mediate Tumor Growth (2023)
    Dong Liu, Chunhui Liang et al. Advanced Science

Immediate Impact

3 from Science/Nature 59 standout
Sub-graph 1 of 23

Citing Papers

Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases
2024 Standout
Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies
2024 Standout

Works of Xiaolong Fu being referenced

Tryptophan Metabolism Acts as a New Anti‐Ferroptotic Pathway to Mediate Tumor Growth
2023 Standout

Author Peers

Author Last Decade Papers Cites
Xiaolong Fu 1324 718 710 178 2.9k
Hyunki Kim 1638 629 1461 277 5.2k
Jürgen Hesser 590 494 562 171 2.6k
Naoyuki Watanabe 324 557 163 148 3.3k
David Bushnell 698 839 1610 212 5.1k
Toshiyuki Sawa 1646 112 1847 264 4.3k
Gary Onik 1550 720 365 101 4.9k
Sharad Goyal 783 537 842 184 2.9k
Jean‐Yves Chapelon 1077 1988 93 167 4.4k
Tadaki Nakahara 713 416 335 171 2.4k
Chandra M. Sehgal 735 1576 158 155 4.3k

All Works

Loading papers...

Rankless by CCL
2026